22. July 2026 | Corporate News

Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration

  • Application for the opening of restructuring proceedings filed
  • Outstanding earn-out payments from Unither Pharmaceuticals and termination of
    negotiations by Unither.
  • Coordination with creditors intended to secure the Company’s sustainable
    continuation
Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration
(72 KB)